SNDX
Syndax Pharmaceuticals Inc
NASDAQ: SNDX · HEALTHCARE · BIOTECHNOLOGY
$20.65
+2.74% today
Updated 2026-05-06
Market cap
$1.69B
P/E ratio
—
P/S ratio
7.79x
EPS (TTM)
$-2.79
Dividend yield
—
52W range
$9 – $26
Volume
1.6M
Syndax Pharmaceuticals Inc (SNDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.02M | $-9.28M | $-7.29M | $-14.39M | $-2.43M | $-35.16M | $-47.37M | $-68.53M | $-50.61M | $-71.26M | $29.13M | $-133.68M | $-160.60M | $-274.90M | $-322.98M |
| Capital expenditures | $8000.00 | $11000.00 | $38000.00 | $4000.00 | $49000.00 | $261000.00 | $84000.00 | $187000.00 | $129000.00 | $129000.00 | $129000.00 | $225000.00 | $0.00 | $0.00 | $187000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $139000.00 | $1.42M | $2.26M | $3.88M | $4.71M | $5.45M | $6.20M | $6.00M | $9.06M | $13.32M | $16.02M | $30.95M | $43.03M | $47.50M |
| Free cash flow | $-10.03M | $-9.29M | $-7.33M | $-14.40M | $-2.48M | $-35.42M | $-47.45M | $-68.72M | $-50.74M | $-71.39M | $29.00M | $-133.90M | $-160.60M | $-274.90M | $-323.17M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $2.60M | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $665000.00 | $11.32M | $-1.40M | $-9.26M | $90.63M | $106.72M | — | — | — | — |